Kenvue Inc. (KVUE)
NYQ · Consumer Defensive · Household & Personal Products
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
About Kenvue Inc.
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 3.8B | 3.8B | 3.8B | 3.9B |
| Gross Profit | 2.3B | 2.2B | 2.1B | 2.3B |
| Operating Income | 752.0M | 713.0M | 632.0M | 838.0M |
| Net Income | 420.0M | 398.0M | 330.0M | 474.0M |
| Diluted EPS | $0.22 | $0.21 | $0.17 | $0.25 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 14.9B | 15.4B | 15.5B | 15.1B |
| Gross Profit | 8.3B | 8.6B | 9.0B | 8.8B |
| Operating Income | 2.7B | 2.5B | 2.6B | 2.7B |
| Net Income | 2.1B | 1.7B | 1.0B | 1.5B |
| Diluted EPS | $1.09 | $0.90 | $0.54 | $0.76 |